Slide 1A phase I study of CHR-2797, an orally active aminopeptidase inhibitor, in elderly and/or treatment refractory patients with acute myeloid leukemia or multiple myeloma…

1.NK Cells Experimental Basis of Immunology January 17, 2007   W.H. Chambers, Ph.D. G.17e Hillman Cancer Center 623-3218 [email_address] 2. I.Introduction Natural Killer…

1. Bone marrow is a highlycellular structure presentwithin the hollow cavities ofhard bone tissueThere is 2 types of bonemarrow:A)red bone marrowB)yellow bone…

1. Natural Killer Cells January 21, 2009 Penny Morel [email_address] , 4-0343 2. Innate capacity of lysis Large granular lymphocytes CD3 - , CD16 + , CD56 + , CD122 + , CD158…

STEM CELLS FOR LUNG DISEASE BY Dr- MOUSA ELSHAMLY Lecturer of chest diseases Faculty of medicine AL-Azhar University October 2007 Stem Cells for Lung Disease Introduction:…

1. Bone marrow Muhammad Asif Zeb Lecturer Hematology IPMS- KMU 2. Anatomy.. 3. What is bone marrow • Bone marrow is a highly cellular, viscus , and highly vascular tissue…

Slide 1 Stable epigenetic reprogramming of bone marrow MSC in patients with MM Sarah Essex Slide 2 MM niche - bone marrow Both primary and malignant plasma cells localise…

Slide 1 Chronic myelogenous leukemia Slide 2 Classification of Myeloid Neoplasms According to the 2008 World Health Organization Classification Scheme Slide 3 ● CML results…

Slide 1 Chronic myeloid leukemia Slide 2 ● The myeloproliferative diseases (MPDs) are clonal stem cell disorders characterised by leukocytosis, thrombocytosis, erythrocytosis,…